Before revision:  Triple negative tumors, SUM149 and MDA-MB-321, resulted in a significantly (p<0.05) higher endothelial permeability and decreased endothelial coverage  compared to the control TIME only platform.
After revision:  Triple negative tumors, SUM149 and MDA-MB-231 platforms exhibited a significantly (p<0.05) higher endothelial permeability and decreased endothelial coverage compared to the control TIME only platform.